Workflow
昊帆生物(301393.SZ):上半年净利润7588.48万元 同比增长15.31%

Group 1 - The core viewpoint of the article is that Haofan Bio (301393.SZ) reported a significant increase in revenue and net profit for the first half of 2025, indicating strong business performance [1] Group 2 - The company achieved an operating income of 270 million yuan, representing a year-on-year growth of 20.10% [1] - The net profit attributable to shareholders of the listed company was 75.8848 million yuan, showing a year-on-year increase of 15.31% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 62.0004 million yuan, with a year-on-year growth of 4.58% [1] - The basic earnings per share were reported at 0.71 yuan [1]